Schmuck et al. have also shown that in patients with biochemical recurrence or PSA persistence after primary therapy for PCa, tumor-to-background ratios have increased at later imaging time-points using [68Ga]PSMA I&T 44. Here, FOLH1 is linked to posterior cortical atrophy.